" class="no-js "lang="en-US"> Ono Pharmaceutical - Medtech Alert
Saturday, August 23, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Ono Pharmaceutical | Pharmtech Focus

Ono Pharmaceutical

About Ono Pharmaceutical

Ono Pharmaceutical

Related Story

News

 Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer | MTA

Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

May 16 2023

Personalis, the National Cancer Center, and Ono Pharmaceutical today announced they have entered into a […]

News

 Ono Pharmaceutical to Acquire Multiple Research-Stage Oncology Programs Identified with KSQ’s CRISPRomics | PTF

Ono Pharmaceutical to Acquire Multiple Research-Stage Oncology Programs Identified with KSQ’s CRISPRomics

January 25 2023

KSQ Therapeutics, a clinical-stage biotechnology company developing therapies to treat cancer and autoimmune diseases using […]

Industry News

 Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases | Pharmtech Focus

Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases

January 17 2022

Neurimmune AG today announced that it has signed an expanded drug discovery collaboration agreement with […]

Artificial Intelligence

 Healx Launches AI-powered Indication Expansion Partnership with Ono Pharmaceutical Co. Ltd. | Pharmtech Focus

Healx Launches AI-powered Indication Expansion Partnership with Ono Pharmaceutical Co. Ltd.

August 6 2021

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced […]